Edwards Lifesciences Sells Surgical Unit
- Share via
Edwards Lifesciences Corp. in Irvine said Monday that it completed the sale of a surgical-services unit to a German company, Fresenius Medical Care, for $45 million in cash.
The “perfusion unit,” Cardiovascular Resources Inc. in San Diego, provides hospitals with clinicians who operate heart-lung machines during open-heart surgery.
Edwards’ stock climbed to a 52-week high of $27.10 before closing Monday at $26.30, up 6 cents a share, on the New York Stock Exchange. Bloomberg News
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
